A Long-term Follow-up of Adult Kidney and Liver Allograft Recipients Previously Enrolled Into a Tacrolimus (Advagraf) Trial. A Multicentre Non-interventional Post Authorization Study (PAS)
Phase of Trial: Phase IV
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection; Renal transplant rejection
- Focus Therapeutic Use
- Acronyms ADDRESS
- Sponsors Astellas Pharma
- 26 Jul 2017 Planned End Date changed from 1 Nov 2018 to 1 Jan 2018.
- 26 Jul 2017 Planned primary completion date changed from 1 Nov 2018 to 1 Jan 2018.
- 21 Mar 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.